Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 10/2022

21-06-2022 | Letter to the Editor

Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population

Authors: Xiao-Dong Liu, Kun Yang, Jian Xiao, Hui Huang, Xiao-Dan Zhang, Jing-Yuan Huang

Published in: Annals of Hematology | Issue 10/2022

Login to get access

Excerpt

Dear Editor, …
Literature
1.
He BJ, Liao L, Deng ZF, Tao YF, Xu YC, Lin FQ (2018) Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematol 139(1):60–66CrossRef
2.
Perrotta S, Gallagher PG, Mohandas N (2008) Hereditary spherocytosis. Lancet 372(9647):1411–1426CrossRef
3.
Hu S, Jue D, Albanese J, Wang Y, Liu Q (2019) Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma. Ann Diagn Pathol 39:86–91CrossRef
4.
Richmond CM, Campbell S, Foo HW et al (2020) Rapid identification of biallelic SPTB mutation in a neonate with severe congenital hemolytic anemia and liver failure. Mol Syndromol 11(1):50–55CrossRef
5.
Yang X, Wang W, Fan W et al (2022) Hereditary spherocytosis with liver transplantation after cirrhosis: a case report. Front Med (Lausanne) 9:823724CrossRef
Metadata
Title
Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population
Authors
Xiao-Dong Liu
Kun Yang
Jian Xiao
Hui Huang
Xiao-Dan Zhang
Jing-Yuan Huang
Publication date
21-06-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-022-04900-0

Other articles of this Issue 10/2022

Annals of Hematology 10/2022 Go to the issue

Letter to the Editor

Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis

Letter to the Editor

A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report

Original Article

Amyloidosis and COVID-19: experience from an amyloid program in Canada

Original Article

Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study

Original Article

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Letter to the Editor

Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits